Scientists are turning venom, radioisotopes, engineered proteins, and AI into powerful new tools against cancer. From ...

A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child ...

UK and ASEAN Strengthen Collaboration on Responsible Engineering Biology for a Sustainable Bioeconomy Bangkok, 10 November 2025 - The United Kingdom ...

Penn and CHOP researchers will utilize the new protocol to distribute customizable drugs that target specific genetic disorders.

Academics and policymakers convened at Presidency University to debate gene-edited rice in India. Discussions explored its ...

The unsung heroes of the lab and lecture hall have laid the groundwork for some of the most transformative technologies of ...

At the conference, Acuitas' Chief Scientific Officer, Dr. Ying Tam, showcased the company's Next-Generation LNP advancements, a comprehensive approach that uses multiple technologies and strategies to ...

Steven Salzberg, Mihaela Pertea, and Winston Timp were named to Clarivate's 2025 Highly Cited Researchers list for pioneering ...

Elevidys now carries a black box warning for acute liver injury and failure, limiting its use to ambulatory patients aged four and older. The FDA's actions follow fatal liver failure reports in ...

The identification of 20 causal plasma proteins for prostate cancer represents a critical step toward addressing the need for improved diagnostic specificity and reveals promising new targets for ...

A habitat-building coralline algae that provides a vital nursing ground for marine species and an important blue carbon ...

AAV-SLB101 is a rationally designed capsid developed for enhanced skeletal muscle, cardiac tropism, and reduced biodistribution to the liver.